Related Experiment Videos
Ebastine overdose in a child
Luca Pecoraro1, Giulia Paiola1, Angelo Pietrobelli1
1Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics University of Verona Verona Italy.
Clinical Case Reports
|April 12, 2017
Insights
Ebastine, an antihistamine, demonstrated a favorable safety profile in a 44-month-old child after a high-dose ingestion. This suggests potential for reduced hospital stays in pediatric cases involving such events.
Area of Science:
- Pediatric Pharmacology
- Clinical Toxicology
Background:
- Antihistamines are commonly used for allergic conditions in children.
- Assessing the safety of acute high-dose medication ingestion is crucial for pediatric care.
Observation:
- A 44-month-old child ingested a high dose of ebastine.
- The child was monitored for adverse effects following the ingestion.
Findings:
- No adverse side effects were observed after the acute high-dose ingestion of ebastine.
- This indicates a potentially robust safety profile for ebastine even at elevated doses in young children.
Implications:
- The findings support the overall safety of ebastine in pediatric populations.
- This may lead to shorter hospitalization durations for children experiencing similar accidental high-dose ingestions, reducing healthcare burden.
Abstract:
The lack of side effects after acute ingestion of a high dose of ebastine in our child aging 44 months suggests an overall safety profile of ebastine; it could suggest less time of hospitalization for children who are subjected to this event.